Loading presentation...

Present Remotely

Send the link below via email or IM


Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.


Vaccine titres - efficacy, safety and regulatory

No description

Robert Pottie

on 8 April 2013

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Vaccine titres - efficacy, safety and regulatory

  MaxRT Minimum Release Titre MED / MPD / EOSLT Increasing titre

  Maximum Release Titre Minimum Effective Dose Increasing titre Animal-defined titres Product-defined titres An enthusiast's guide to vaccine titres Robert Pottie International requirements Titre: A form of defining concentration by means of titration - the amount of organism in a quantity of vaccine (MED, or Minimum Protective Dose, MPD) How do we define effective? e.g. Pasteurella vaccine monograph: Control group: Vaccinated group: Does MED = EOSLT (End of Shelf Life Titre?) Depends on jurisdiction The maximum dose safe for the animal How do we define safe? Regulatory requirements include:
Repeat 1xMaxRT doses
Specific monograph thresholds (MaxRT) Target titre (MinRT) Defined primarily by the stability of the product The MinRT is set to ensure the product stays above EOSLT until at least the expiry date Not required by any regulator

The basis of productions calculations

Accounts for variation inherent in production and assay variation

Balances MinRT with wastage Therefore, tightly linked to EOSLT and shelf life (Animal-defined) (Product-defined) Australia (APVMA)
MaxRT US (CVB): MED defines EOSLT Japan: Minimum titre (MED) ~MaxRT >70% affected >70% unaffected *
Full transcript